tiprankstipranks
Trending News
More News >
NurExone Biologic (TSE:NRX)
:NRX
Canadian Market

NurExone Biologic (NRX) Cash flow

Compare
11 Followers

NurExone Biologic Cash Flow

TSE:NRX's free cash flow for Q3 2024 was $―. For the 2024 fiscal year, TSE:NRX's free cash flow was decreased by $-3.21B and operating cash flow was $―. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 13.26B$ 14.72B$ 11.50B$ 5.71B$ 2.40B
Investing Cash Flow
$ ―$ ―$ ―$ ―$ ―
Financing Cash Flow
$ ―$ ―$ ―$ ―$ ―
End Cash Position
$ ―$ ―$ ―$ ―$ ―
Free Cash Flow
$ 4.36B$ 7.57B$ 5.01B$ 2.55B$ 1.07B
Currency in USD

NurExone Biologic Cash Flow